Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Cash, Cash Equivalents and Investments

v3.24.1.1.u2
Note 5 - Cash, Cash Equivalents and Investments
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Cash, Cash Equivalents, and Marketable Securities [Text Block]

5.    Cash, cash equivalents and investments

 

As of  March 31, 2024 and December 31, 2023, cash, cash equivalents and investments comprised funds in depository, money market accounts and U.S. treasury securities. The following tables present the cash equivalents and investments carried at fair value in accordance with the hierarchy defined in Note 2 at March 31, 2024 and December 31, 2023.

 

   

Total

   

Quoted prices in active markets (Level 1)

   

Significant other observable inputs (Level 2)

   

Significant unobservable inputs (Level 3)

 

March 31, 2024

                               

Money market funds, included in cash equivalents

  $ 8,143     $ 8,143     $     $  

US treasuries, included in cash equivalents

    7,921       7,921              

Total

  $ 16,064     $ 16,064     $     $  

 

   

Total

   

Quoted prices in active markets (Level 1)

   

Significant other observable inputs (Level 2)

   

Significant unobservable inputs (Level 3)

 

December 31, 2023

                               

Money market funds, included in cash equivalents

  $ 13,224     $ 13,224     $     $  

Investments - US treasuries

    8,970       8,970              

Total

  $ 22,194     $ 22,194     $     $  

 

Cash equivalents and marketable securities have been initially valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third party pricing services or other market observable data. The pricing services utilize industry standard valuation models, including both income and market-based approaches and observable market inputs to determine value. The Company validates the prices provided by its third-party pricing services by reviewing their pricing methods and obtaining market values from other pricing sources, as needed. After completing its validation procedures, the Company did not adjust any fair value measurements provided by the pricing services as of March 31, 2024.

 

The Company recorded no realized gains or losses from the maturity of available-for-sale securities during the three months ended March 31, 2024 and recorded $0.1 million in realized losses from the maturity of available-for-sale securities during the three months ended March 31, 2023.